Zhejiang Huakang Pharmaceutical Co., Ltd.

SHSE:605077 주식 보고서

시가총액: CN¥4.3b

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Zhejiang Huakang Pharmaceutical 관리

관리 기준 확인 1/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Deshui Chen

최고 경영자

n/a

총 보상

CEO 급여 비율n/a
CEO 임기no data
CEO 소유권15.9%
경영진 평균 재임 기간데이터 없음
이사회 평균 재임 기간데이터 없음

최근 관리 업데이트

Recent updates

Zhejiang Huakang Pharmaceutical (SHSE:605077) Will Want To Turn Around Its Return Trends

Sep 26
Zhejiang Huakang Pharmaceutical (SHSE:605077) Will Want To Turn Around Its Return Trends

Improved Earnings Required Before Zhejiang Huakang Pharmaceutical Co., Ltd. (SHSE:605077) Shares Find Their Feet

Jul 02
Improved Earnings Required Before Zhejiang Huakang Pharmaceutical Co., Ltd. (SHSE:605077) Shares Find Their Feet

Zhejiang Huakang Pharmaceutical (SHSE:605077) May Have Issues Allocating Its Capital

May 28
Zhejiang Huakang Pharmaceutical (SHSE:605077) May Have Issues Allocating Its Capital

We Think That There Are Some Issues For Zhejiang Huakang Pharmaceutical (SHSE:605077) Beyond Its Promising Earnings

May 02
We Think That There Are Some Issues For Zhejiang Huakang Pharmaceutical (SHSE:605077) Beyond Its Promising Earnings

CEO

Deshui Chen (54 yo)

no data

테뉴어

CN¥1,505,800

보상

Mr. Deshui Chen is Chairman of the Board & GM of Zhejiang Huakang Pharmaceutical Co. Ltd.